^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    SIBP-04 (bevacizumab biosimilar)

    i
    Company:
    Sinopharm
    Drug class:
    VEGF-A inhibitor, Angiogenesis inhibitor
    Related drugs: